Adherence to anti-tuberculosis chemoprophylaxis and treatment in children

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 1, 2006, Pages 13-18

  Van Zyl, S ^a   Marais, B J ^a   Hesseling, A C ^a   Gie, R P ^a   Beyers, N ^a   Schaaf, H Simon ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Adherence; Chemoprophylaxis; Children; Treatment

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ARTICLE; BACTERIUM ADHERENCE; CHEMOPROPHYLAXIS; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFECTION RATE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTH AFRICA; STUDENT T TEST;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DRUG THERAPY, COMBINATION; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RIFAMPIN; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 33144467578     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Beyers N, Gie R P, Schaaf H S, et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 38-43.
2. Topley J M, Maher D, Nyong'onya Mbewe L. Transmission of tuberculosis to contacts of sputum positive adults in Malawi. Arch Dis Child 1996; 74: 140-145.
3. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402.
4. World Health Organization. Tuberculosis in children. In: Treatment of tuberculosis: Guidelines for National Programmes. 3rd ed. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003: 61-66.
5. Enarson D A, Rieder H L, Arnadottir T, Trébucq A. Treating the disease. In: Management of tuberculosis: a guide for low income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000: pp 11-24.
6. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976; 57: 275-299.
7. Marais B J, Gie R P, Schaaf H S, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 278-285.
8. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
9. Ormerod L P. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998; 78: 169-171.
10. Claessens N J M, Gausi F F, Meijnen S, Weismuller M M, Salaniponi F M, Harries A D. Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 2002; 6: 362-364.
11. Verver S, Warren R M, Munch Z, et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 2004; 363: 212-214.
12. Harries A D, Maher D. Diagnosis of tuberculosis in children. In: TB/HIV, a clinical manual. WHO/TB/96.200. Geneva, Switzerland: WHO, 1996: 61-68.
13. Smuts N A, Beyers N, Gie R P, et al. Value of the lateral chest radiograph in tuberculosis in children. Pediatr Radiol 1994; 24: 478-480.
14. Wilkinson D, Davies G R. Pediatric tuberculosis in rural South Africa-value of directly observed therapy. J Trop Pediatr 1998; 44: 266-269.
15. Guwatudde D, Nakakeeto M, Jones-Lopez E C, et al. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol 2003; 158: 887-898.
16. Alperstein G, Morgan K R, Mills K, Daniels L. Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Aust N Z J Public Health 1998; 22: 210-213.
17. Reichler M R, Reves R, Bur S, et al. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J 2002; 95: 414-420.
18. Bock C K, Metzger B S, Tapia J R, Blumberg H M. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med 1999; 159: 295-300.
19. Ena J, Vails V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005; 40: 670-676.
20. Department of Health, South Africa. National Tuberculosis Control Programme: Practical guidelines 1996. Pretoria, South Africa: Department of Health, 1996.
21. Department of Health, South Africa. National Tuberculosis Control Programme: Practical guidelines 2000. Pretoria, South Africa: Department of Health, 2000.
22. Schaaf H S, Gie R P, Kennedy M, Beyers N, Hesseling P B, Donald P R. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 2002; 109: 765-771.
23. Donald P R. Preventing tuberculosis in childhood. Indian J Pediatr 2000; 67: 383-385.
24. Marks S M, Taylor Z, Qualls N L, Shrestha-Kuwahara R J, Wilce M A, Nguyen C H. Outcome of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162: 2033-2038.